Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Cancer Growth Factor
63%
Colorectal Carcinoma
59%
Receptor
51%
Breast Cancer
43%
Lung Metastasis
31%
Liver Fibrosis
29%
Phosphotransferase Inhibitor
29%
Phosphotransferase
25%
Tissue Inhibitor of Metalloproteinase 1
19%
Focal Adhesion Kinase
19%
Paclitaxel
19%
Janus Kinase 1
19%
Cancer Growth
15%
Neoplasm
15%
Reactive Oxygen Metabolite
14%
Metastasis
14%
Kidney Fibrosis
13%
Mouse Model
13%
Carcinogenesis
11%
Therapy Resistance
10%
Fibrosis
10%
N Benzyl 1,2,3,4,8,9 Hexahydro 6 (4 Hydroxybenzyl) 8 (1 Naphthylmethyl) 4,7 Dioxo 2h pyrazino[1,2 A]pyrimidine 1(6h) Carboxamide
9%
Triple Negative Breast Cancer
9%
Doublecortin
9%
Lymphoid Enhancer Factor 1
9%
Lung Fibrosis
9%
Intestinal Homeostasis
9%
Niclosamide
9%
Leucine
9%
G Protein Coupled Receptor
9%
Microbiome
9%
Base
9%
Janus Kinase
9%
Cyclin D2
9%
Carbon Tetrachloride
7%
Mouse Mammary Tumor Virus
7%
Western Blot
7%
Recurrent Disease
6%
Rat Model
6%
Fibronectin
5%
Breast Tumor
5%
Transforming Growth Factor Beta1
5%
Bleomycin
5%
Chromatin Immunoprecipitation
5%
Therapeutic Effect
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
92%
Cancer Stem Cell
29%
Phosphotransferase
26%
Kinase
26%
Stem Cell
25%
Cancer Growth Factor
24%
Wnt Signaling Pathway
24%
Mesenchymal-Epithelial Transition
21%
Metalloprotease Inhibitor
19%
Hepatic Stellate Cell
19%
Janus Kinase 1
19%
Doublecortin
19%
Mouse Model
16%
Small Molecule
12%
Knockout Mouse
11%
Homeostasis
11%
Myeloid
9%
Mosaicism
9%
Lymphoid Enhancer-Binding Factor 1
9%
Intron
9%
X Ray
9%
Cyclin D2
9%
STAT3
9%
Janus Kinase
9%
Radiosensitivity
9%
Signal Transduction
8%
Cell Survival
7%
N-Ethylmaleimide
7%
Cell Invasion
6%
Cell Growth
6%
Cell Proliferation
5%
Medicine and Dentistry
Colorectal Carcinoma
39%
Cancer Cell
39%
Cancer Stem Cell
29%
Malignant Neoplasm
24%
Radiosensitivity
19%
Radiation Therapy
13%
Phosphotransferase
11%
Therapy Resistance
10%
Triple Negative Breast Cancer
9%
Lymphoid Enhancer Factor 1
9%
Niclosamide
9%
Phosphotransferase Inhibitor
9%
Lung Metastasis
9%
Cancer Stem Cell Line
9%
Cyclin D2
9%
Janus Kinase
9%
Intestinal Stem Cell
9%
Cancer Growth Factor
9%
Neoplasm
9%
Chemoradiotherapy
8%
Metastatic Carcinoma
7%
Recurrent Disease
5%
Signal Transduction
5%